Naphazoline Hydrochloride/Chlorphenamine Maleate/Cyanocobalamin

盐酸萘甲唑啉/马来酸氯苯那敏/维生素B12

Report date: 2023/08/11 09:18:43
NME

Base Information

Drug NameNaphazoline Hydrochloride/Chlorphenamine Maleate/Cyanocobalamin
Drug Alias Name萘敏维闪亮康业萘敏维滴眼液青山利康萘敏维滴眼液润洁 +[13] 
ClassificationSmall molecules
Mechanisms of ActionAlpha adrenergic receptor agonistsHistamine H1 receptor antagonistsMethylmalonyl-CoA Mutase stimulants
TargetsAlpha adrenergic receptorHistamine H1 receptorMethylmalonyl-CoA Mutase
Therapy Area/IndicationsVisual AcuityEye Diseases
Global Approved IndicationsEye Diseases
Approved Indications in ChinaEye Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryUnited StatesMainland China
CombinationsYes Naphazoline HydrochlorideChlorphenamine MaleateCyanocobalamin
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson Vision Care IncChina Otsuka Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsVisual AcuityEye Diseases
Inactive IndicationsN/A

Other Information

ATC CodeS01GA51
Related LinksN/A